1910 Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
43
- Latest Deal Type
-
Later Stage VC
- Investors
-
16
1910 General Information
Description
Developer of a drug discovery platform intended to offer small and large molecule drug discovery with a multimodal AI platform powered by laboratory automation. The company's platform offers new end-to-end drug discovery and development processes that must be reimagined from the ground up using AI, enabling clients to improve productivity and decrease failure rates across the pharmaceutical development process.
Contact Information
Website
www.1910.aiCorporate Office
- 451 D Street
- Suite 905
- Boston, MA 02210
- United States
Corporate Office
- 451 D Street
- Suite 905
- Boston, MA 02210
- United States
1910 Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Later Stage VC | 31-Oct-2024 | Completed | Generating Revenue | |||
| 4. Grant | 29-Jun-2021 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | 23-Mar-2021 | $25.7M | $25.8M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Jan-2019 | $125K | $125K | Completed | Startup |
1910 Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-6 | ||||||||
| Series A-5 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | ||||||||
| Series A-2 | 476,321 | $0.000100 | 8% | $1.36 | $1.36 | 1x | $1.36 | 2.83% |
| Series A-1 | 4,516,639 | $0.000100 | 8% | $4.87 | $4.87 | 1x | $4.87 | 26.83% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
1910 Comparisons
Industry
Financing
Details
1910 Competitors (14)
One of 1910’s 14 competitors is BioMap, a Venture Capital-Backed company based in Palo Alto, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BioMap | Venture Capital-Backed | Palo Alto, CA | ||||
| Atomic AI | Venture Capital-Backed | San Francisco, CA | ||||
| Terray Therapeutics | Venture Capital-Backed | Monrovia, CA | ||||
| Exscientia | Formerly VC-backed | Oxford, United Kingdom | ||||
| PostEra | Venture Capital-Backed | Cambridge, MA |
1910 Patents
1910 Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026117739-A1 | Keto amide compounds as calpain inhibitors | Pending | 27-Nov-2024 | ||
| US-20250257051-A1 | Substituted pyrimidine compounds as tyk2 inhibitors | Pending | 28-Jul-2022 | ||
| WO-2024026430-A1 | Substituted pyrimidine compounds as tyk2 inhibitors | Inactive | 28-Jul-2022 | ||
| FR-2853396-A1 | Electronic photophore for reproducing natural flame, has leds supplied by rechargeable batteries, control card controlling supply of led, and microprocessor placed on card for controlling ignition and extinction of led | Inactive | 01-Apr-2003 | F21S9/02 |
1910 Signals
1910 Investors (16)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accenture Technology Ventures | Corporate Venture Capital | Minority | ||
| Foobar | Family Office | Minority | ||
| NVIDIA | Corporation | Minority | ||
| 1945 Capital | Family Office | Minority | ||
| Apollo (VC) | Venture Capital | Minority |
1910 FAQs
-
When was 1910 founded?
1910 was founded in 2018.
-
Where is 1910 headquartered?
1910 is headquartered in Boston, MA.
-
What is the size of 1910?
1910 has 43 total employees.
-
What industry is 1910 in?
1910’s primary industry is Discovery Tools (Healthcare).
-
Is 1910 a private or public company?
1910 is a Private company.
-
What is 1910’s current revenue?
The current revenue for 1910 is .
-
How much funding has 1910 raised over time?
1910 has raised $25.8M.
-
Who are 1910’s investors?
Accenture Technology Ventures, Foobar, NVIDIA, 1945 Capital, and Apollo (VC) are 5 of 16 investors who have invested in 1910.
-
Who are 1910’s competitors?
BioMap, Atomic AI, Terray Therapeutics, Exscientia, and PostEra are some of the 14 competitors of 1910.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process